BMJ Paediatrics Open · 2026-04-09
P37 Balancing IV medications and parenteral nutrition administration: a neonatal and paediatric audit
Phrase rank #2 · DOI 10.1136/bmjpo-2026-NPPG.46
Treatments & interventions
drugs
Observed in 66 articles across 17 journals.
Latest share0.17%
Change vs baseline-0.00 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- BMJ31
- European Journal of Hospital Pharmacy13
- BMJ Open4
- Journal of Medical Ethics3
- BMJ Supportive & Palliative Care2
- Drug and Therapeutics Bulletin2
- Archives of Disease in Childhood1
- BMJ Connections Oncology1
- BMJ Medicine1
- BMJ Open Ophthalmology1
- BMJ Paediatrics Open1
- BMJ Public Health1
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
BMJ · 2026-03-27
When I use a word . . . Terminology of hallucinogenic agents
Phrase rank #2 · DOI 10.1136/bmj.s606
European Journal of Hospital Pharmacy · 2026-03-18
5PSQ-022 Analysis of exposure to QT-prolonging drugs in lung transplant patients
Phrase rank #2 · DOI 10.1136/ejhpharm-2026-eahp.449
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-328 Developing a screening toll for fall-risk-increasing drugs in a Danish hospital
Phrase rank #2 · DOI 10.1136/ejhpharm-2026-eahp.425
BMJ · 2026-01-30
GLP-1 drugs: New warning after rise in reported deaths from pancreatitis
Phrase rank #2 · DOI 10.1136/bmj.s204
European Journal of Hospital Pharmacy · 2026-03-18
3PC-021 Drug allergy diagnosis using epicutaneous patch tests: insights from a 2-year retrospective study
Phrase rank #3 · DOI 10.1136/ejhpharm-2026-eahp.84
BMJ Connections Oncology · 2026-01-16
Healthcare providers’ knowledge gaps and educational needs in addressing substandard and falsified oncology drugs: a scoping review
Phrase rank #3 · DOI 10.1136/bmjconc-2025-000069
BMJ · 2025-07-22
GP suspended for prescribing drugs to friends for his own use
Phrase rank #3 · DOI 10.1136/bmj.r1540
BMJ · 2026-02-05
Tapering of antidepressants . . . and other stories
Phrase rank #4 · DOI 10.1136/bmj.s160
BMJ · 2026-01-29
New synthetic drugs more powerful than fentanyl pose a new epidemic threat
Phrase rank #4 · DOI 10.1136/bmj.r2653
BMJ · 2025-11-11
Equitable access to costly new drugs
Phrase rank #4 · DOI 10.1136/bmj.r2292
BMJ · 2026-07-08
Comparing benefits and harms of obesity drugs
Phrase rank #5 · DOI 10.1136/bmj-2026-725349
BMJ Open · 2026-05-27
Differential treatment effects across subgroups in immunomodulatory drugs for sepsis: protocol for a systematic review
Phrase rank #5 · DOI 10.1136/bmjopen-2025-108626
Heart · 2026-03-25
Managing glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in clinical practice
Phrase rank #5 · DOI 10.1136/heartjnl-2024-324847
BMJ · 2026-03-20
Alzheimer’s drugs: Lecanemab and donanemab to be reconsidered for NHS after appeal
Phrase rank #5 · DOI 10.1136/bmj.s551
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-272 Medication prescribing among the elderly in Catalonia
Phrase rank #5 · DOI 10.1136/ejhpharm-2026-eahp.370
BMJ · 2026-01-09
New safety warnings for gabapentinoids, benzodiazepines, and z drugs
Phrase rank #5 · DOI 10.1136/bmj.s50
Drug and Therapeutics Bulletin · 2025-09-29
Orphan drugs—striking the right balance
Phrase rank #5 · DOI 10.1136/dtb.2025.000005
BMJ · 2026-02-06
GLP-1 drugs: New eyesight warning for Ozempic/Wegovy
Phrase rank #6 · DOI 10.1136/bmj.s252
BMJ · 2026-01-07
Weight regain after cessation of GLP-1 drugs
Phrase rank #6 · DOI 10.1136/bmj.r2586
BMJ Public Health · 2025-09-17
Generic competition and price developments in the USA, Germany and Switzerland (2007–2023): a longitudinal observational study
Phrase rank #6 · DOI 10.1136/bmjph-2024-002535
BMJ · 2026-03-20
When I use a word . . . The psychedelic mind’s eye
Phrase rank #7 · DOI 10.1136/bmj.s548
European Journal of Hospital Pharmacy · 2026-03-18
6ER-031 Relationship between price of purchase and quality of oral antidiabetic drugs in Sub-Saharan Africa: the diabdaf study
Phrase rank #7 · DOI 10.1136/ejhpharm-2026-eahp.631
European Journal of Hospital Pharmacy · 2026-03-18
4CPS-265 Deprescribing in practice: multidisciplinary review of low therapeutic value drugs in elderly patients
Phrase rank #7 · DOI 10.1136/ejhpharm-2026-eahp.363
BMJ Open Ophthalmology · 2026-01-12
Impact of anticancer drugs on human Tenon’s fibroblast proliferation: implications for glaucoma surgery
Phrase rank #7 · DOI 10.1136/bmjophth-2025-002307
Journal of Scleroderma and Related Disorders · 2026-06-05
P.259 Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies
Phrase rank #8 · DOI 10.1136/JSRD-2026-SSWC.302
BMJ · 2026-05-07
RFK Jr takes aim at “overprescribing” of psychiatric drugs
Phrase rank #8 · DOI 10.1136/bmj.s882
BMJ · 2026-04-30
Weight loss drugs: New tool could help doctors identify those who might benefit from treatments
Phrase rank #8 · DOI 10.1136/bmj.s834
BMJ · 2025-11-18
Weight loss drugs: What do we know about the effects of Ozempic on children?
Phrase rank #8 · DOI 10.1136/bmj.r2387
European Journal of Hospital Pharmacy · 2026-03-18
3PC-023 Simulation of dose banding implementation in the preparation of anticancer drugs
Phrase rank #9 · DOI 10.1136/ejhpharm-2026-eahp.86